With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits. Aside from the impressive results, GLP-1s seem to be increasingly easy for ...

The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

GLP‑1 weight‑loss drugs are reshaping food industry demand, but side effects, cost barriers and unclear long‑term impacts ...

The actress opened up to PEOPLE about her “miraculous” weight loss ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Experts say that improving heart and metabolic health may be key to helping people with severe mental illness live longer, ...

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Retailer offerings trumpet a variety of claims about protein, fat and fibre levels, while some seem to simply be smaller ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

Next gen weight-loss medications are powerful — but eating too little can put some patients at serious nutritional risk.

Young, affluent and health‑driven, GLP‑1 users are reshaping food retail with demand for protein‑rich, nutrient‑dense and convenient meals.